Nexstim Plc: Amendment of the terms of stock options programs and warrants
Company announcement, inside information,
Nexstim Plc: Amendment of the terms of stock options programs and warrants
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (
”Nexstim” or
”Company”) has completed a subscription rights issue which ended on 29 March 2021 in Sweden and on 31 March 2021 in Finland. With reference to the Company announcement published earlier today the Company has also decided on directed share issue. In relation to these rights issues the Board of Directors has today on 7 April 2021 resolved to reduce the share subscription prices of the Company’s stock option programs 2016B-C, 2018A-B and 2020A-C as well as the exercise prices of the outstanding warrant agreements i.e. special rights to shares.
Nexstim Plc: Final results of the successful rights issue
NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO THE UNITED STATES OF AMERICA, AUSTRALIA, SOUTH AFRICA, HONG KONG, JAPAN, CANADA, NEW ZEALAND OR SINGAPORE OR TO ANY OTHER COUNTRY WHERE THE DISTRIBUTION OR PUBLICATION IS ILLEGAL.
According to the final results of the rights issue of Nexstim Plc (NXTMH:HEX, NXTMS:STO) (
“Nexstim” or “
the Company”) (“
the Share Issue”) that ended on 29 March 2021 in Sweden and on 31 March 2021 in Finland, the Share Issue was oversubscribed, and the number of share subscriptions corresponded to 178,13% of the offered shares. Of the 219 811 378 new shares offered in the Share Issue (“
Nexstim Oyj: Nexstim Plc: Final results of the successful rights issue finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Nexstim Oyj: Nexstim Plc: Managers Transactions
Nexstim Plc: Managers Transactions
Person subject to the notification requirement
Name: Järnefelt Gustaf
Instrument type: SHARE
Transaction details
Aggregated transactions
Further information is available on the website www.nexstim.com
, or by contacting:
About Nexstim Plc
Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.
Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.